Neutral
Cue Biopharma (NASDAQ:CUE) Raised to Strong-Buy at Wall Street Zen
Wall Street Zen has upgraded Cue Biopharma (NASDAQ:CUE) to a "strong-buy" rating, despite Weiss Ratings reaffirming a "sell" rating and the overall co...